GAS6/Mer axis regulates the homing and survival of the E2A/PBX1-positive B-cell precursor acute lymphoblastic leukemia in the bone marrow niche

Experimental Hematology

Volumn 38, Issue 2, 2010, Pages 132-140

  Shiozawa, Yusuke ^a   Pedersen, Elisabeth A ^a   Taichman, Russell S ^a  

^a UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST SPECIFIC PROTEIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN MER; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; BONE MARROW; CELL HOMING; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DORMANCY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; OSTEOBLAST; PRE B LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BONE MARROW; CELL LINE, TUMOR; CELL SURVIVAL; CHEMOTAXIS; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; OSTEOBLASTS; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 73949130412     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2009.11.002     Document Type: Article

References (37)

1. Pui C.H., Relling M.V., and Downing J.R. Acute lymphoblastic leukemia. N Engl J Med 350 (2004) 1535-1548
2. Piccaluga P.P., Malagola M., Rondoni M., et al. Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation. Leuk Lymphoma 47 (2006) 469-472
3. Yeoh E.J., Ross M.E., Shurtleff S.A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 1 (2002) 133-143
4. Graham D.K., Salzberg D.B., Kurtzberg J., et al. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clin Cancer Res 12 (2006) 2662-2669
5. Ek S., Hogerkorp C.M., Dictor M., Ehinger M., and Borrebaeck C.A. Mantle cell lymphomas express a distinct genetic signature affecting lymphocyte trafficking and growth regulation as compared with subpopulations of normal human B cells. Cancer Res 62 (2002) 4398-4405
6. Chen J., Carey K., and Godowski P.J. Identification of Gas6 as a ligand for Mer, a neural cell adhesion molecule related receptor tyrosine kinase implicated in cellular transformation. Oncogene 14 (1997) 2033-2039
7. Dormady S.P., Zhang X.M., and Basch R.S. Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6). Proc Natl Acad Sci U S A 97 (2000) 12260-12265
8. Clauser S., Bachelot-Lozat C., Fontana P., et al. Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol 26 (2006) e22
9. Balogh I., Hafizi S., Stenhoff J., Hansson K., and Dahlback B. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol 25 (2005) 1280-1286
10. Burnier L., Borgel D., Angelillo-Scherrer A., and Fontana P. Plasma levels of the growth arrest-specific gene 6 product (Gas6) and antiplatelet drug responsiveness in healthy subjects. J Thromb Haemost 4 (2006) 2283-2284
11. Borgel D., Clauser S., Bornstain C., et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med 34 (2006) 219-222
12. Keating A.K., Salzberg D.B., Sather S., et al. Lymphoblastic leukemia/lymphoma in mice overexpressing the Mer (MerTK) receptor tyrosine kinase. Oncogene 25 (2006) 6092-6100
13. Miura Y., Gao Z., Miura M., et al. Mesenchymal stem cell-organized bone marrow elements: an alternative hematopoietic progenitor resource. Stem Cells 24 (2006) 2428-2436
14. Taichman R.S. Blood and bone: two tissues whose fates are intertwined to create the hematopoietic stem-cell niche. Blood 105 (2005) 2631-2639
15. Patt H.M., and Maloney M.A. Bone formation and resorption as a requirement for marrow development. Proc Soc Exp Biol Med 140 (1972) 205-207
16. Lord B.I., and Hendry J.H. The distribution of haemopoietic colony-forming units in the mouse femur, and its modification by x rays. Br J Radiol 45 (1972) 110-115
17. Calvi L.M., Adams G.B., Weibrecht K.W., et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
18. Taichman R.S., and Emerson S.G. Human osteoblasts support hematopoiesis through the production of granulocyte colony-stimulating factor. J Exp Med 179 (1994) 1677-1682
19. Zhang J., Niu C., Ye L., et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
20. Arai F., Hirao A., Ohmura M., et al. Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118 (2004) 149-161
21. Ninomiya M., Abe A., Katsumi A., et al. Homing, proliferation and survival sites of human leukemia cells in vivo in immunodeficient mice. Leukemia 21 (2007) 136-142
22. Lehr J.E., and Pienta K.J. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. J Natl Cancer Inst 90 (1998) 118-123
23. Gothot A., Pyatt R., McMahel J., Rice S., and Srour E.F. Functional heterogeneity of human CD34(+) cells isolated in subcompartments of the G0 /G1 phase of the cell cycle. Blood 90 (1997) 4384-4393
24. Kiel M.J., Yilmaz O.H., Iwashita T., Terhorst C., and Morrison S.J. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121 (2005) 1109-1121
25. Bewick M.A., and Lafrenie R.M. Adhesion dependent signalling in the tumour microenvironment: the future of drug targetting. Curr Pharm Des 12 (2006) 2833-2848
26. Li Z.W., and Dalton W.S. Tumor microenvironment and drug resistance in hematologic malignancies. Blood Rev 20 (2006) 333-342
27. Ramasamy R., Lam E.W., Soeiro I., Tisato V., Bonnet D., and Dazzi F. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21 (2007) 304-310
28. Mudry R.E., Fortney J.E., York T., Hall B.M., and Gibson L.F. Stromal cells regulate survival of B-lineage leukemic cells during chemotherapy. Blood 96 (2000) 1926-1932
29. Matsunaga T., Takemoto N., Sato T., et al. Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia. Nat Med 9 (2003) 1158-1165
30. Holland S.J., Powell M.J., Franci C., et al. Multiple roles for the receptor tyrosine kinase axl in tumor formation. Cancer Res 65 (2005) 9294-9303
31. Budagian V., Bulanova E., Orinska Z., et al. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol Cell Biol 25 (2005) 9324-9339
32. van Ginkel P.R., Gee R.L., Shearer R.L., et al. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res 64 (2004) 128-134
33. Sainaghi P.P., Castello L., Bergamasco L., Galletti M., Bellosta P., and Avanzi G.C. Gas6 induces proliferation in prostate carcinoma cell lines expressing the Axl receptor. J Cell Physiol 204 (2005) 36-44
34. Wu Y.M., Robinson D.R., and Kung H.J. Signal pathways in up-regulation of chemokines by tyrosine kinase MER/NYK in prostate cancer cells. Cancer Res 64 (2004) 7311-7320
35. Linger R.M., Deryckere D., Brandao L., et al. Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia. Blood 24 114 (2009) 2678-2687
36. Yin T., and Li L. The stem cell niches in bone. J Clin Invest 116 (2006) 1195-1201
37. Shiozawa Y., Havens A.M., Pienta K.J., and Taichman R.S. The bone marrow niche: habitat to hematopoietic and mesenchymal stem cells, and unwitting host to molecular parasites. Leukemia 22 (2008) 941-950